Square Pharmaceuticals Ltd. reported earnings results for the second quarter and six months ended December 31, 2022. For the second quarter, the company reported sales was BDT 18,715.14 million compared to BDT 16,432.3 million a year ago. Revenue was BDT 16,187.08 million compared to BDT 14,195.38 million a year ago. Net income was BDT 5,126.18 million compared to BDT 4,644.33 million a year ago. Basic earnings per share from continuing operations was BDT 5.78 compared to BDT 5.24 a year ago.
For the six months, sales was BDT 37,528.42 million compared to BDT 33,849.84 million a year ago. Revenue was BDT 32,256.71 million compared to BDT 29,072.24 million a year ago. Net income was BDT 10,626.49 million compared to BDT 9,641 million a year ago. Basic earnings per share from continuing operations was BDT 11.99 compared to BDT 10.88 a year ago.